Chen Weiwei, Rogatsky Inez, Garabedian Michael J
Department of Microbiology, New York University Cancer Institute, New York University School of Medicine, 550 First Avenue, New York, New York 10016, USA.
Mol Endocrinol. 2006 Mar;20(3):560-72. doi: 10.1210/me.2005-0318. Epub 2005 Oct 20.
The Mediator subunits MED14 and MED1 have been implicated in transcriptional regulation by the glucocorticoid receptor (GR) by acting through its activation functions 1 and 2. To understand the contribution of these Mediator subunits to GR gene-specific regulation, we reduced the levels of MED14 and MED1 using small interfering RNAs in U2OS-hGR osteosarcoma cells and examined the mRNA induction by dexamethasone of four primary GR target genes, interferon regulatory factor 8 (IRF8), ladinin 1, IGF-binding protein 1 (IGFBP1), and glucocorticoid-inducible leucine zipper (GILZ). We found that the GR target genes differed in their requirements for MED1 and MED14. GR-dependent mRNA expression of ladinin 1 and IRF8 required both MED1 and MED14, whereas induction of IGFBP1 mRNA by the receptor was dependent upon MED14, but not MED1. In contrast, GILZ induction by GR was largely independent of MED1 and MED14, but required the p160 cofactor transcriptional intermediary factor 2. Interestingly, we observed higher GR occupancy at GILZ than at the IGFBP1 or IRF8 glucocorticoid response element (GREs). In contrast, recruitment of MED14 compared with GR at IGFBP1 and IRF8 was higher than that observed at GILZ. At GILZ, GR and RNA polymerase II were recruited to both the GRE and the promoter, whereas at IGFBP1, RNA polymerase II occupied the promoter, but not the GRE. Thus, MED14 and MED1 are used by GR in a gene-specific manner, and the requirement for the Mediator at GILZ may be bypassed by increased GR and RNA polymerase II occupancy at the GREs. Our findings suggest that modulation of the Mediator subunit activities would provide a mechanism for promoter selectivity by GR.
中介体亚基MED14和MED1通过糖皮质激素受体(GR)的激活功能1和2参与转录调控。为了解这些中介体亚基对GR基因特异性调控的作用,我们在U2OS-hGR骨肉瘤细胞中使用小干扰RNA降低MED14和MED1的水平,并检测了地塞米松对四个主要GR靶基因(干扰素调节因子8(IRF8)、层粘连蛋白1、胰岛素样生长因子结合蛋白1(IGFBP1)和糖皮质激素诱导亮氨酸拉链(GILZ))的mRNA诱导情况。我们发现,GR靶基因对MED1和MED14的需求各不相同。层粘连蛋白1和IRF8的GR依赖性mRNA表达需要MED1和MED14两者,而受体对IGFBP1 mRNA的诱导依赖于MED14,而非MED1。相比之下,GR对GILZ的诱导在很大程度上不依赖于MED1和MED14,但需要p160辅因子转录中介因子2。有趣的是,我们观察到GR在GILZ上的占据率高于在IGFBP1或IRF8糖皮质激素反应元件(GREs)上的占据率。相比之下,MED14在IGFBP1和IRF8上与GR的募集高于在GILZ上观察到的情况。在GILZ处,GR和RNA聚合酶II被募集到GRE和启动子上,而在IGFBP1处,RNA聚合酶II占据启动子,但不占据GRE。因此,GR以基因特异性方式使用MED14和MED1,并且在GILZ处对中介体的需求可能通过GR和RNA聚合酶II在GREs上的占据增加而被绕过。我们的研究结果表明,中介体亚基活性的调节将为GR的启动子选择性提供一种机制。